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Tuberculosis (TB) in humans is caused bymembers of theMycobacterium tuberculosis complex (MTC). The accurate identification of
theMTCmember causing human infection is important because the treatment of TB caused by someMTCmembers requires an alter-
ation of the standard drug regimen, it can informwhether transmission is human to humanor zoonotic, and it enables accurate epide-
miology studies that help improveTB control. In this study, an internally controlled two-stagemultiplex real-timePCR-basedmethod,
SeekTB,was developed for the accurate identification of allmembers of theMTC. Themethodwas tested against a panel ofwell-char-
acterized bacterial strains (n 180) and determined to be 100% specific formembers of theMTC.Additionally, 125Mycobacteria
Growth Indicator Tube (MGIT)-positive cultureswere blindly tested by using SeekTB, and the resultswere compared to those of the
GenoTypeMTBCandTBc ID tests. The SeekTBandGenoTypeMTBC resultswere 100%concordant, identifying 84 of these isolates as
M. tuberculosis isolates and 41 as non-MTC isolates. Nine discordant results between themolecularmethods and the TBc ID culture
confirmation test were observed; however, nucleotide sequencing confirmed the results obtainedwithGenoTypeMTBCand SeekTB.
SeekTB is the first-described internally controlledmultiplex real-timePCRdiagnosticmethod for the accurate identification of all eight
members of theMTC. Thismethod, designed for use on cultured patient samples, is specific, sensitive, and rapid, with a turnaround
time to results of approximately 1.5 to 3.5 h, depending onwhich, if any,member of theMTC is present.
Tuberculosis (TB) remains a major health concern in both de-veloped anddeveloping countries due to the high rates ofmor-
bidity and mortality associated with this disease. In 2010, there
were an estimated 8.5 to 9.2 million incident cases of TB globally,
with an associated 1.5 million deaths, 23% of which were associ-
ated with HIV coinfection (28).
The Mycobacterium tuberculosis complex (MTC) comprises
eight members (M. tuberculosis,M. canettii,M. africanum,M. bo-
vis, M. caprae, M. microti, M. pinnipedii, and the attenuated M.
bovisBCGvaccine strain),99% similar on a nucleotide sequence
level, that are responsible for causing TB in humans (5).
WhileM. tuberculosis is responsible for the majority of cases of
human TB, the accurate identification of other MTC members
that cause infection is not routinely performed (21). As a result,
the global frequency and distribution of each MTC member re-
main largely unknown, with some studies suggesting that TB
caused by members of the MTC other than M. tuberculosis are
more prevalent than previously reported (1, 26).M.africanum, for
example, has been identified as the causative agent of up to 50%of
human TB infections in West African countries (15), and M. ca-
nettii was responsible for 10% of TB cases in a recent study
performed in theRepublic ofDjibouti (17). Furthermore,M.bovis
remains an important cause of zoonotic TBworldwide and should
not be overlooked in a clinical setting (1, 12). In developing coun-
tries, where there is a paucity of data, one study suggested that the
prevalence of bovine TB in humans may be as high as 15% (8).
SomeMTCmembers (M. bovis,M. bovisBCG, andM. canettii)
are intrinsically resistant to pyrazinamide (PZA), an important
first-line anti-TB drug (26). Therefore, the specific identification
of thesemembers of theMTC is clinically important for treatment
management decisions. This highlights the need for a rapid diag-
nostic assay that is capable of differentiating the members of the
MTC while simultaneously providing information relating to
contact and source tracing.
Currently, there is only one commercially available diagnostic as-
say for the differentiation of theMTC, namely, the GenotypeMTBC
kit (Hain Lifesciences GmbH, Nehren, Germany). While useful for
identifying somemembersof theMTC, this kit is limitedby its inabil-
ity to accurately identify M. tuberculosis, M. canettii, M. africanum,
andM. pinnipedii (16). There have also been a number ofmolecular-
basedassays forMTCdifferentiationdescribed in the literature (9, 11,
13, 20, 21). These methods are also limited by an inability to differ-
entiate all members of theMTC, andmost of these methods require
postamplification processing, which increases method complexity,
analysis time, and potential contamination.
Previously, we have reported the design and development of
two 4-plex real-time PCR diagnostic assays for the accurate iden-
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tification of the MTC, one for the identification ofM. tuberculosis
andM. canettii and one for the identification ofM. bovis,M. bovis
BCG, and M. caprae (22, 23). In this study, additional diagnostic
targets were incorporated into these 4-plex assays, resulting in two
5-plex real-time PCR diagnostic assay. By incorporating these tar-
gets, we have now devised a diagnostic method and an algorithm
which allow for the accurate identification of the MTC and the
differentiation of all 8members, including the capability to differ-
entiate between M. africanum West African 1 and M. africanum
West African 2. This two-stagemethod, SeekTB, can be performed
in approximately 3.5 h post-DNA extraction.
MATERIALS AND METHODS
Ethics statement. This study was approved by the research ethics review
committee of the University of Zambia School ofMedicine, Ridgeway Cam-
pus, Lusaka, Zambia. All study participants gavewritten informed consent in
accordance with internationally recognized clinical trial standards.
Bacterial isolates used in this study. The panel ofMTC isolates, non-
tuberculosismycobacteria (NTM), and other bacterial species used in this
study (see Tables S1 and S2 in the supplemental material) was the same
panel as that described in a previous study (23), with the addition of 47
MTC isolates provided by the National Reference Center for Mycobacte-
ria, Borstel, Germany (characterized as described previously by Allix-Bé-
guec et al. [2]). All genomicDNA samples used in this study were isolated,
quantified, and stored as described previously (22).
PCR primers and hydrolysis probe design. The novel diagnostic tar-
gets used in this study were identified by using in silico comparative
genomic approaches previously described (22, 23). All oligonucleotides
used in this study were designed in accordance with previously reported
guidelines (10, 24). All primers and probes (see Table S3 in the supple-
mental material) were designed with similar properties to facilitate mul-
tiplexing (23).
ConventionalPCRand sequencing.Conventional PCRamplification
of the RD713 region (2,798-bpM. africanumWest African 1) and RD701
(340-bpM. africanumWest African 2) was performed according tometh-
ods described previously by Huard et al. (14). Genomic DNA was also
amplified for sequencing to confirm the identity of some clinical isolates.
The sequencing primers (see Table S3 in the supplemental material) were
used in conventional PCRs as previously described (22, 23). PCRproducts
were purified and sequenced according to methods described previously
by Reddington et al. (23).
Real-time PCR. Multiplex real-time PCRs were performed with a
LightCycler 480 instrument using the LightCycler 480 Probes Master kit
(Roche Diagnostics). The optimized PCRmix for multiplex 1 contained 2
LightCycler 480 Probes Master mix (6.4 mM MgCl2); forward and reverse
primers (0.5 M final concentration); Cyan 500-, carboxy-X-rhodamine
(ROX)- and Cy5-labeled probes (0.2Mfinal concentration) in addition to
4,4,7,2,4,5,7-hexachloro-6-carboxyfluorescein (HEX)-labeled (0.1 M final
concentration) and 6-carboxyfluorescein (FAM)-labeled (0.4Mfinal con-
centration) probes; dimethyl sulfoxide (4%; Sigma-Aldrich, MO); and tem-
plate DNA (MTC, 2l; internal amplification control [IAC], 2l; NTM, 10
l), adjusted to a final volume of 40 l with the addition of nuclease-free
distilled water (dH2O). TheM. smegmatis internal control DNA was diluted
to contain 100 genome equivalents per 2 l, and NTMDNA was diluted to
contain104 genome equivalents per 10 l. For multiplex 2, the optimized
PCRmix was the same, with the exception of the FAM-labeled probe, where
a 0.2 M final concentration was sufficient. PCR cycling was performed as
previously described (22). To avoid fluorescence leaking from channel to
channel, a color compensation filewas generated (3), and the noise bandwas
set to 1.2 fluorescence units (multiplex 1) and 1.3 fluorescence units (multi-
plex 2) in the Cyan 500, FAM, HEX, and ROX channels.
Evaluation of SeekTB performance on clinical cultures. Genomic
DNA from 125 Mycobacteria Growth Indicator Tube (MGIT)-positive
culture samples isolated at the University Teaching Hospital, Lusaka,
Zambia, were tested blindly. Positive MGIT cultures were identified as
MTC or non-MTC by using the TBc ID (BD Diagnostics) test, according
to the manufacturer’s instructions, before DNA extraction. Isolated DNA
samples were also tested by using the GenoType MTBC kit (Hain Life-
sciences) according to the manufacturer’s instructions.
RESULTS
Diagnostics targets.During this study, it was determined that the
wbbl1 assay, outlined previously for the specific detection of M.
tuberculosis-M. canettii isolates (22), also detected M. africanum
West African 1. Therefore, an additional assay for the specific
detection ofM. africanumWest African 1was necessary. Region of
difference (RD) 713 was previously identified as specific to M.
africanumWest African 1 (7, 19, 27). RDs represent regions of the
genome present inM. tuberculosis that are deleted in other mem-
bers of the MTC (4). In members of the MTC with intact RD 713,
this region is 4,248 bp, whereas in M. africanum West African 1,
this region is 2,798 bp (14, 27). An assay targeting a 138-bp region
of RD713 (primers RD_713Fw and RD_713Rv and probe RD713
[see Table S3 in the supplemental material]) was designed for the
specific detection ofM. africanumWest African 1 and was incor-
porated into the first multiplex assay. The MTC-specific probe
was also redesigned to improve specificity (see Table S3 in the
supplemental material).
The second multiplex real-time PCR diagnostic assay was
modified from a previously described multiplex assay (23), by
incorporating an assay for the specific detection of M. africanum
West African 2. PCR primers RD701_Fw and RD_701 and probe
RD701 were designed to amplify an 81-bp region of RD 701, an
RD specific toM. africanumWest African 2 (7, 19, 27) (see Table
S3 in the supplemental material). In members of the MTC with
intact RD 701, this region is 2,885 bp, whereas in M. africanum
West African 2, this region is 340 bp (27).
The incorporation of an additional diagnostic assay to each of
the above-describedmultiplex assays resulted in two 5-plex assays
capable of differentiating all 8 members of the MTC and the 2M.
africanum clades (see Fig. S1 and S2 in the supplementalmaterial).
Specificities of the diagnostic assays. The specificities of all
monoplex assays were evaluated against a panel of 180 MTC,
NTM, and other bacteria (see Tables S1 and S2 in the supplemen-
tal material). Subsequently, the specificities of the assays were re-
evaluated in a multiplex format. All assays were 100% specific for
the target organisms in both monoplex and multiplex formats.
Using multiplex 1, the RD 713 assay was specific for the 5 M.
africanumWestAfrican 1 isolates tested. Thewbbl1 assaywas specific
for the 60 M. tuberculosis, 8 M. canettii, and 5 M. africanum West
African1 isolates tested.TheMTCassaywas specific for the119MTC
isolates tested. The RDcanettii1 assay was specific for the detection of
the 8M. canettii isolates tested. The IAC (targeting MSMEG_0660)
was specific for the detection ofM. smegmatisDNA.
Using multiplex 2, the lepA assay was specific for the detection
of the 5M. caprae isolates tested. The RD 701 assay was specific for
the 5M. africanumWest African 2 isolates tested. The lpqT assay
was specific for the 14 M. bovis, 7 M. bovis BCG, and 5 M. caprae
isolates tested. The diagnostic assay targeting RD 1 did not detect
any of the 7 M. bovis BCG strains tested but detected all M. bovis
and M. caprae strains tested, allowing for the specific identifica-
tion ofM. bovis BCG. The IAC assay was 100% specific.
A typical representation of the amplification curves generated
Reddington et al.
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in each of the analysis channels in the two multiplex assays is
shown in Fig. S1 and S2 in the supplemental material.
Sensitivities of the assays. The lower limit of detection (LOD)
of the assays was determined by using probit regression analysis
(22, 23). LODs of 9.04, 5.88, 0.4, and 5.08 genome equivalents for
theMTC-specific (lepA),M. tuberculosis-M. canettii-M. africanum
West African 1-specific (wbbl1), M. canettii-specific (RDcanettii1),
andM. africanumWest African 1-specific (RD713) assays, respec-
tively, were determined.
For multiplex 2, LODs of 5.66, 6.05, 98.28, and 24.9 genome
equivalents for the M. bovis-M. bovis BCG-M. caprae (lpqT), M.
bovis-M. caprae (RD1),M. caprae (lepA), andM. africanumWest
African 2 (RD701) assays, respectively, were determined. In both
multiplex assays, the IAC at a concentration of 100 cell equivalents
was detected in all samples tested.
Interpretation of results. The interpretation of the multiplex
assay results was performed as described in Table 1.When isolates
are tested, multiplex 1 should always be performed first. If the
sample is positive for a member of the MTC but M. tuberculosis,
M. canettii, orM. africanumWest African 1 is not identified, mul-
tiplex 2 should subsequently be performed. Multiplex 2 directly
identifies M. bovis, M. bovis BCG, M. caprae, and M. africanum
West African 2. To identify the remaining members of the MTC,
namely,M. microti andM. pinnipedii, the combined results from
both multiplex assays must be taken into account. Assay results
can be easily interpreted according to Table 1.
Evaluation of SeekTB performance with clinical cultures.
MGIT-positive isolates were blindly tested by using two molecular
methods, the GenoTypeMTBC (Hain Lifesciences) line probe assay
and SeekTB. Both molecular methods demonstrated 100% agree-
ment, identifying 84 isolates asM. tuberculosis isolates and 41 isolates
as non-MTC isolates. The results of TBc ID (with a reported specific-
ity and sensitivity of 92.4 to 100%and 94.9 to 100%, respectively [18,
25, 29]) and the molecular methods were concordant for 79 MTC
isolates and 37 non-MTC isolates. The ssrA genes of the 9 discordant
samples were sequenced to consolidate results. Nucleotide sequence
analysis revealed that themolecular tests were correct for 8 out of the
9 discordant isolates. The remaining isolate returned a mixed se-
quence, possibly indicating the presence of a mixed culture contain-
ing bothMTC and non-MTC species.
DISCUSSION
The accurate differentiation of members of the MTC is necessary
to (i) perform epidemiological studies, (ii) monitor whether TB
transmission is human to human or zoonotic (9, 21), and (iii)
administer appropriate anti-TB treatment, due to some members
of the complex displaying natural resistance to PZA (1, 26).
The method described in this study, SeekTB, is composed of
two 5-plex real-time PCR assays which can be performed sequen-
tially. The first multiplex diagnostic assay has the capability of
detecting the presence of the MTC isolate while simultaneously
differentiatingM. tuberculosis,M. canettii, andM. africanumWest
African 1, taking approximately 1.5 h to complete after DNA ex-
traction. For themajority of TB cases, only the firstmultiplex assay
would have to be performed, asM. tuberculosis is thought to be the
causative agent of approximately 95% of human infections (6).
The second multiplex diagnostic assay would be performed if a
member of the MTC was detected in the sample but M. tubercu-
losis, M. canettii, or M. africanum West African 1 was not identi-
fied. The secondmultiplex assay enables the specific identification
of the remaining members of the complex, namely, M. bovis, M.
bovis BCG, M. caprae, M. africanum West African 2, M. microti,
andM. pinnipedii. The sequential performance of both tests takes
approximately 3.5 h after DNA extraction.
The specificity of the diagnostic targets used in this study
was initially tested by using a panel of well-defined MTC isolates.
These isolates were previously characterized by using methods
such as spoligotyping, mycobacterial interspersed repetitive-
unit–variable-number tandem-repeat (MIRU-VNTR) analysis,
IS6110-based typing methods, RD analysis, and biochemical test-
ing in addition to morphological examination. The developed
method demonstrated 100% agreement with the previously used
methods, correctly identifying all members of theMTC and dem-
onstrating the robustness of the rapid tests developed.
TABLE 1 Result scenario for each member of the MTCa
Multiplex
assay
Result with analysis channel and target
Result interpretationbCyan 500 FAM HEX ROX Cy5
1 RD 713 wbbl1 MTC lepA RDcanettii1 IAC MSMEG_0660
     M. africanumWest African 1
     M. canettii
     M. tuberculosis
     MTC—perform second multiplex
     Not a member of the MTC
     Result invalid, test must be repeated
2 M. caprae lepA lpqT RD 1 RD 701 Cy5 (IAC MSMEG_0660)
     M. caprae
     M. bovis
     M. bovis BCG
     M. africanumWest African 2
     M. pinnipedii
     M. microti
     Result invalid, test must be repeated
a, positive signal observed;, positive signal not observed.
b The interpretations of the results of the multiplex 2 assay take into account the multiplex 1 results.
Molecular Differentiation of the MTC
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A further evaluation of the SeekTB method was performed by
blindly testing apanel ofuncharacterizedpositiveMGITcultures and
comparing the results with those generated by using the GenoType
MTBC test. The results of both molecular methods demonstrated
100%agreement; however, somediscordancewasobservedwhen the
results of thesemolecularmethodswere compared to culture results.
The concordant molecular method results were indicative of true
results in this study, as confirmed by nucleotide sequencing.
While the characterization of the MGIT-positive culture sam-
ples resulted in the identification ofM. tuberculosis only, it should
be noted that this is a relatively small number of isolates from one
urban geographical region. MGIT-positive culture sample bio-
banks with a high likelihood of containing a variety ofmembers of
the MTC are required to further validate SeekTB (and the novel
diagnostic targets used). The additional testing of a larger panel of
MGIT-positive culture samples from this region and other regions
worldwide will be performed in future.
When comparing the two molecular methods tested, the
SeekTBmethod offers a number of advantages over the GenoType
line probe assay: the developedmethod is less laborious, requiring
less hands-on time; there is no need for the postamplification
handling of samples, which significantly reduces the likelihood of
introducing contamination; there is an enhanced sensitivity with
the real-time-PCR-based SeekTB method; and SeekTB has the
ability to accurately identifyM. tuberculosis,M. canettii,M. pinni-
pedii, and both clades ofM. africanum in addition to themembers
of the MTC identifiable by using the GenoType MTBC test.
In conclusion, the diagnostic method developed in this study,
SeekTB, is the first-described internally controlled, multiplex-PCR-
basedmethod capable of rapidly and accurately identifying all mem-
bers of theMTC. This method has been validated on a large panel of
well-characterized MTC isolates and has been successfully used for
the culture confirmation of positive African MGIT cultures. Ulti-
mately,SeekTBneeds tobe further tested in thefield, bothonpositive
culture samples and directly on clinical samples, such as sputum, to
demonstrate its potential and robustness for the specific identifica-
tion and differentiation of isolates of theMTC.
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